Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital

Journal of Microbiology, Immunology and Infection

Volumn 41, Issue 3, 2008, Pages 200-208

  Liang, Shiou Haur ^a   Lo, Yi Chun ^b   Lin, Hsi Hsun ^a   Chang, Sui Yuan ^c   Chen, Mao Yuan ^b   Hsieh, Szu Min ^b   Sheng, Wang Huei ^b   Sun, Hsin Yun ^b   Hung, Chien Ching ^b   Chang, Shan Chwen ^b  

^a I SHOU UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Endocarditis; Hepatitis, viral, human; HIV infection; Substance abuse, intravenous; Tuberculosis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; TUBERCULOSTATIC AGENT; VIRUS RNA; HEPATITIS B ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; CATHETER INFECTION; CD4+ T LYMPHOCYTE; CELL COUNT; CELLULITIS; CLINICAL STUDY; DEMOGRAPHY; DRUG USE; EPIDURAL ABSCESS; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GRAM POSITIVE BACTERIUM; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTIOUS COMPLICATION; KIDNEY ABSCESS; LABORATORY TEST; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; NONHUMAN; OSTEOMYELITIS; PATIENT CARE; PATIENT REFERRAL; PERITONITIS; PNEUMONIA; PREVALENCE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROPREVALENCE; SEX RATIO; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; TAIWAN; URINARY TRACT INFECTION; VIRUS LOAD; BLOOD; CD4 LYMPHOCYTE COUNT; ENDOCARDITIS; EPIDEMIOLOGY; HOSPITAL; ISOLATION AND PURIFICATION; MIDDLE AGED; SUBSTANCE ABUSE; TUBERCULOSIS;

ADULT; AGED; BACTEREMIA; CD4 LYMPHOCYTE COUNT; ENDOCARDITIS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HOSPITALS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; STAPHYLOCOCCUS AUREUS; SUBSTANCE ABUSE, INTRAVENOUS; TAIWAN; TUBERCULOSIS; VIRAL LOAD;

EID: 53749100069     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. AIDS epidemic update: December 2006. UNAIDS/WHO; 2006:1-86.
2. Aceijas C, Stimson GV, Hickman M, Rhodes T; United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004;18:2295-303.
3. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and dependent areas, 2005. HIV/AIDS Surveillance Report. 2007;17: 1-54. Available from: http://www.cdc.gov/hiv/topics/ surveillance/resources/reports/2005report/
4. Centers for Disease Control, Taiwan. HIV/AIDS data, 2006. Available from: http://www.cdc.gov.tw/website-en/health%20topics/ Communicable%20Diseases%20&%20Prevention/Issues%20of%20HIV-AIDS/ Statistics%20 of%20HIVAIDS/Download%20HIV-AIDS%20Data.files/2006.files/ 9512Monthly%20Report.pdf
5. Chen YM, Kuo SH. HIV-1 in Taiwan. Lancet. 2007;369: 623-5.
6. Miró JM, del Río A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin. 2003;21:167-84.
7. White AG. Medical disorders in drug addicts. 200 consecutive admissions. JAMA. 1973;223:1469-71.
8. Brettle RP. Infection and injection drug use. J Infect. 1992;25:121-31.
9. Friedman H, Newton C, Klein TW. Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev. 2003;16:209-19.
10. Chung DC, Ko YC, Chen CJ, Chen ER, Wu CC, Wu PS. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan. J Med Virol. 1989;28:215-8.
11. Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis. 1990;162:817-22.
12. Chen CH, Yang PM, Huang GT, Lee HS, Sung JL, Sheu JC. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc. 2007;106:148-55.
13. Morice Y, Roulot D, Grando V, Stirnemann J, Gault E, Jeantils V, et al. Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns. J Gen Virol. 2001;82:1001-12.
14. Kumar S, Tamura K, Jakobsen IB, Nei M. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics. 2001;17:1244-5.
15. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-40.
16. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977;296:1305-9.
17. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200-9.
18. Sun HY, Chen MY, Hsieh SM, Sheng WH, Chang SY, Hsiao CF, et al. Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy. Jpn J Infect Dis. 2006;59:311-6.
19. Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, Chang SC. Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection. Int J STD AIDS. 2005;16:42-8.
20. Tedaldi EM, Baker RK, Moorman AC, Alzola CF, Furhrer J, McCabe RE, et al. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2003;36:363-7.
21. Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis. 1996;174:690-5.
22. Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001;33:562-9.
23. Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis. 2002;186:1023-7.
24. Yoo TW, Donfield S, Lail A, Lynn HS, Daar ES; Hemophilia Growth and Development Study. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis. 2005;191:4-10.
25. Sheng WH, Chen MY, Hsieh SM, Hsiao CF, Wang JT, Hung CC, et al. Impact of chronic hepatitis B virus (HBV) infection on outcomes of patients infected with HIV in an area where HBV infection is hyperendemic. Clin Infect Dis. 2004;38:1471-7.
26. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med. 2001;135:796-800.
27. Petrosillo N, Viale P, Nicastri E, Arici C, Bombana E, Casella A, et al. Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors. Clin Infect Dis. 2002;34:677-85.
28. Wang JT, Sheng WH, Chen MY, Fang CT, Hsieh SM, Hsueh PR, et al. Nosocomial bloodstream infection in human immunodeficiency virus-infected patients in Taiwan: descriptive epidemiology and risk factors for mortality. J Formos Med Assoc. 2004;103:743-8.
29. Tumbarello M, de Gaetano Donati K, Tacconelli E, Citton R, Spanu T, Leone F, et al. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother. 2002;50:375-82.
30. McDonald LC, Lauderdale TL, Lo HJ, Tsai JJ, Hung CC. Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Int J STD AIDS. 2003;14:473-7.
31. Nguyen MH, Kauffman CA, Goodman RP, Squier C, Arbeit RD, Singh N, et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med. 1999;130:221-5.
32. Chang FY, MacDonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore). 2003;82:322-32.
33. Manoff SB, Vlahov D, Herskowitz A, Solomon L, Muñoz A, Cohn S, et al. Human immunodeficiency virus infection and infective endocarditis among injecting drug users. Epidemiology. 1996;7:566-70.
34. Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med. 1993;119:1017-28.
35. Perlman DC, Salomon N, Perkins MP, Yancovitz S, Paone D, Des Jarlais DC. Tuberculosis in drug users. Clin Infect Dis. 1995;21:1253-64.
36. Guidelines for implementing collaborative TB and HIV programme activities. World Health Organization; 2003:1-78.
37. Castilla J, Gutiérrez A, Guerra L, Pérez de la Paz J, Noguer I, Ruiz C, et al. Pulmonary and extrapulmonary tuberculosis at AIDS diagnosis in Spain: epidemiological differences and implications for control. AIDS. 1997;11:1583-8.
38. Raviglione MC, Sudre P, Rieder HL, Spinaci S, Kochi A. Secular trends of tuberculosis in western Europe. Bull World Health Organ. 1993;71:297-306.
39. Chaves F, Dronda F, Cave MD, Alonso-Sanz M, Gonzalez-Lopez A, Eisenach KD, et al. A longitudinal study of transmission of tuberculosis in a large prison population. Am J Respir Crit Care Med. 1997;155:719-25.
40. Shepherd SM, Druckenbrod GG, Haywood YC. Other infectious complications in intravenous drug users. The compromised host. Emerg Med Clin North Am. 1990;8:683-92.